SCD and Miyoshi myopathy: MM cells show enhanced levels of stearoyl-CoA desaturase 1 (SCD1) and acetyl-CoA acetyltransferase 2 (ACAT2), resulting in resistance to BRAFi (Vergani et al., 2022).